title: Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: a post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS).
authors: Jian-Jun
authors: JJ
authors: Li
authors: Zong-Liang
authors: ZL
authors: Lu
authors: Wen-Rong
authors: WR
authors: Kou
authors: Roberto
authors: R
authors: Bolli
authors: Zuo
authors: Z
authors: Chen
authors: Yang-Feng
authors: YF
authors: Wu
authors: Xue-Hai
authors: XH
authors: Yu
authors: Yu-Cheng
authors: YC
authors: Zhao
mesh_terms: D002318:Cardiovascular Diseases / Q000150:complications / Q000517:prevention & control*; D002681:China; D004311:Double-Blind Method; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008107:Liver Diseases / Q000150:complications; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D012307:Risk Factors; D055502:Secondary Prevention; D013997:Time Factors
chemical_list: D004365:Drugs, Chinese Herbal; C496822:xuezhikang